Our site uses cookies to make navigation as function as possible, including “third party” cookies and “profiling cookies” designed to tailor
on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your
consent to some or all cookies, click here. If you proceed with browsing this website, you will be consenting to the use of all cookies.

董事会

董事会负责制定公司政策和目标,审核管理委员会提出的计划。董事会致力于高标准的公司治理,确保美纳里尼亚太公司始终按照其核心愿景和价值观发展。

Ernest Wong
董事会主席
A. Menarini Asia-Pacific Holdings Pte. Ltd.
Pietro Giovanni Corsa
总经理
A. Menarini Industrie Farmaceutiche, Riunite Srl
Lastrucci Luca
公司董事
公司新领域及新兴市场总监
A. Menarini Industrie Farmaceutiche Riunite s.r.l

董事会
首席执行官
A.Menarini Asia-Pacific Holdings Pte Ltd
Lim Wee Hann
合资人
合并与收购主管
Rajah & Tann Singapore LLP
Stefano Pieri
公司董事
许可和业务发展
A. Menarini Industrie Farmaceutiche, Riunite Srl
Christopher Tay
董事会
首席行政官
A.Menarini Asia-Pacific Holdings Pte Ltd

美纳里尼基金会

该基金会成立于 1976 年...

GO TO SITE

美纳里尼在亚太地区

搜索我们的公司

主要品牌

专题文章

Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for Commercializing LIXIANA® in the Philippines, Malaysia and Singapore

READ MORE